4.1(top 3%)
Impact Factor
4.4(top 3%)
extended IF
79(top 5%)
H-Index
1.8K
authors
2K
papers
42.8K
citations
5.7K
citing journals
34.8K
citing authors

Most Cited Articles of Expert Opinion on Drug Safety

TitleYearCitations
Clinical consequences of polypharmacy in elderly2014863
DPP-4 inhibitors: pharmacological differences and their clinical implications2014562
Safety of aerosolized amphotericin B2007476
Paclitaxel: a review of adverse toxicities and novel delivery strategies2007281
An overview on safety issues related to erythropoiesis-stimulating agents for the treatment of anaemia in patients with chronic kidney disease2016253
Long-term side effects of glucocorticoids2016249
Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis2014219
A review of the efficacy and safety of oral antidiabetic drugs2013205
Drug-induced phospholipidosis: issues and future directions2006196
Statin-induced myopathy: a review and update2011194
Statin use and cancer risk: a comprehensive review2010190
A systematic review of the safety of probiotics2014186
Fluoropyrimidine-associated cardiotoxicity: revisited2009181
Glial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity2005181
Adverse reactions to first-line antituberculosis drugs2006178
Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine2014177
Renal adverse effects of nonsteroidal anti-inflammatory drugs2009169
The role of data mining in pharmacovigilance2005169
Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis2016161
A review of existing and emerging digital technologies to combat the global trade in fake medicines2017160
Thiazolidinedione safety2012159
The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms2006159
Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety2006156
Hydroxychloroquine in systemic lupus erythematosus (SLE)2017153
An update on the clinical consequences of polypharmacy in older adults: a narrative review2018147